The effects of oral administration of Spirulina Platensis (cultured Iranian) on blood glucose and glycosylated Hemoglobin blood in type II diabetes mellitus patients

Objectives: The effect of oral administration of Spirulina Platensis (cultured Iranian type) on the blood glucose and glycosylated Hemoglobin in type II diabetes mellitus patients. Design: the participants will be selected from male and female type 2 diabetics admitted to the Diabetes Research Center (with the range of 30 to 60 years old, and 5-10 years history of oral anti-diabetic therapy). After completing the relevant questionnaire, at least 50 cases (non-randomized) with fasting blood glucose between 126-300 mgr/dl and HbA1c >7 mgr/ dl will be selected. However, smokers, patients with underlying diseases as well as pregnant and breastfeeding women will be excluded from the study. Setting and Intervention: The patients will be divided into two groups: a control group (only receiving oral anti-diabetic medications) and a treatment group who will receive Spirulina platensis powder concentrate 8 grams per day (In three divided doses every 8 hours) in addition to their previous treatment. These patients will be monitored for 90 days. Main Outcome Measures: The patients’ blood glucose level will be measured (after 12 hours fasting) at 0, 30, 60 and 90 days after the intervention; their HbA1c levels will be recorded both at the beginning and at the end of study.

Vice chancelator for research of Ferdowsi University of Mashhad - Nano chemical cell company (Manufacturer and provider of Spirulina platensis powder)